Wells Fargo
PPH icon

Wells Fargo’s VanEck Pharmaceutical ETF PPH Stock Holding History

Wells Fargo’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,200
Closed -$721K – 7324
2025
Q2 		$721K Buy
+8,200
New +$711K ﹤0.01% 3905

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Wells Fargo's PPH Position: Q1 2026 in Review

Wells Fargo reduced its VanEck Pharmaceutical ETF (PPH) stake by 100% in Q1 2026, selling an estimated $53.2M and leaving 431 shares worth $44.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5491.

Wells Fargo first reported a position in PPH in Q2 2013 and has held it in 51 quarters since. The position peaked at $51.6M in Q4 2025. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Wells Fargo held 431 shares of VanEck Pharmaceutical ETF worth $44.8K as of Q1 2026.
  • Wells Fargo sold 499,674 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $53.2M.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5491 holding.
  • Wells Fargo first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 51 quarters since.
  • Wells Fargo's VanEck Pharmaceutical ETF position peaked at $51.6M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.